Step 1 topics → Respiratory → Inhaled and Systemic Corticosteroids

Inhaled and Systemic Corticosteroids

USMLE Step 1 trap: Believes inhaled corticosteroids provide immediate bronchodilation, when their anti-inflammatory effect is delayed by hours to days. Corticosteroids act by inhibiting phospholipase A2 (via lipocortin) and reducing inflammatory gene transcription; their anti-inflammatory effects take hours to days and they do not cause acute bronchodilation.

Corticosteroids in respiratory pharmacology split into two very different clinical beasts: inhaled (ICS) and systemic. USMLE Step 1 loves this topic because students consistently blur the lines between the two — same drug class, but wildly different side effect profiles and clinical roles. The mechanism is also testable at a molecular level, not just 'it reduces inflammation.' You need to know that glucocorticoids bind intracellular receptors, upregulate lipocortin (annexin A1), inhibit phospholipase A2, and ultimately suppress arachidonic acid metabolism — cutting off both prostaglandin and leukotriene synthesis. On top of that, they directly suppress inflammatory gene transcription (NF-κB inhibition). None of this happens in minutes.

The exam tests corticosteroids from three main angles: the molecular mechanism, the local toxicities of ICS, and the systemic toxicities plus HPA suppression from prolonged oral or IV use. Passage-based questions often present a patient who's been on long-term prednisone and asks what happens if it's stopped abruptly — this is a classic trap. Application questions will describe an acute asthma attack and ask which drug provides immediate relief, expecting you to know ICS is the wrong answer there. Beclomethasone, fluticasone, budesonide, and mometasone are the high-yield ICS agents — they're interchangeable for Step 1 purposes.

What makes this tricky is the layered misconception structure. Students know corticosteroids are anti-inflammatory, but they overestimate how fast they work and conflate inhaled with systemic toxicity. The oral candidiasis point sounds minor but shows up repeatedly — it's a direct consequence of local immunosuppression in the oropharynx, and it's preventable with mouth rinsing. Miss these distinctions and you'll lose points on questions that feel straightforward.

From real student decks
70%have cards covering this topic
54%have mature cards

Common misconceptions

Common mistake
Wrong: Inhaled corticosteroids provide immediate bronchodilation during an acute asthma attack.
Right: Corticosteroids act by inhibiting phospholipase A2 (via lipocortin) and reducing inflammatory gene transcription; their anti-inflammatory effects take hours to days and they do not cause acute bronchodilation.
Corticosteroids are not bronchodilators — they don't relax airway smooth muscle at all. Their mechanism requires gene transcription changes and protein synthesis (lipocortin production), which takes hours to days to translate into reduced airway inflammation. In an acute asthma attack, you reach for a short-acting beta-2 agonist like albuterol for immediate relief; corticosteroids are given concurrently to dampen the underlying inflammatory cascade, but they won't rescue a patient in the next few minutes.
Common mistake
Wrong: Inhaled corticosteroids cause the same systemic side effects as oral corticosteroids at equivalent doses.
Right: Inhaled corticosteroids primarily cause local side effects (oral candidiasis, dysphonia) and have minimal systemic effects at standard doses; patients should rinse their mouth after use to prevent candidiasis.
Inhaled corticosteroids stay largely in the airways and oropharynx at standard doses — they don't reach systemic levels high enough to cause the classic systemic steroid toxicities (hyperglycemia, osteoporosis, Cushing's syndrome) the way oral prednisone does. The trade-off is that concentrated drug deposits in the mouth and throat cause local immunosuppression, creating a perfect environment for Candida albicans overgrowth. This is why mouth rinsing after each ICS use is standard practice — it removes drug from the oropharynx before it can suppress local immunity.
Common mistake
Gap: Missing understanding that abrupt discontinuation of long-term systemic corticosteroids can cause adrenal crisis due to HPA axis suppression
Prolonged systemic corticosteroid use suppresses the HPA axis, and abrupt discontinuation can precipitate adrenal crisis; doses must be tapered after extended use.
When exogenous corticosteroids are given for weeks or longer, the hypothalamic-pituitary-adrenal (HPA) axis receives continuous negative feedback and essentially stops producing ACTH, causing the adrenal cortex to atrophy. If you abruptly stop the exogenous steroid, the adrenals can't suddenly resume full cortisol production — the patient is left without either exogenous or endogenous glucocorticoids, which can precipitate adrenal crisis (hypotension, hyponatremia, hypoglycemia, shock). The fix is a slow taper to give the HPA axis time to recover; this is one of the most tested 'what happens when you stop' scenarios on Step 1.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Understand the molecular mechanism of glucocorticoids: how binding to intracellular receptors leads to lipocortin upregulation, phospholipase A2 inhibition, and suppression of inflammatory gene transcription — and why this means the effect is delayed, not immediate.
  2. Know the local side effects specific to inhaled corticosteroids (oral candidiasis, dysphonia) and why they differ from systemic toxicities — including the clinical intervention (mouth rinsing) that prevents the most common local complication.
  3. Recognize the indications for systemic corticosteroids in respiratory disease and their major toxicities, including HPA axis suppression with prolonged use and the risk of adrenal crisis upon abrupt discontinuation.

Can you avoid these mistakes?

A patient with severe acute asthma is brought to the ER. You give IV methylprednisolone along with albuterol. Ninety minutes later, the patient asks why the steroid isn't helping yet. What is the correct explanation, and how does this relate to the drug's mechanism of action?
A patient on fluticasone inhaler for 6 months develops white plaques on the buccal mucosa. What is the diagnosis, what caused it, and what simple instruction could have prevented it?
A patient with COPD has been on oral prednisone 40 mg/day for 3 months. Their pulmonologist decides to stop it. What happens if they discontinue abruptly, and what is the physiological explanation?
Which of the following is NOT a side effect of inhaled corticosteroids at standard doses: (A) oral candidiasis, (B) dysphonia, (C) osteoporosis, (D) none — all are expected? Explain your reasoning.

Related topics

Lung Development Stages Surfactant Production and Neonatal RDS Bronchopulmonary Dysplasia Congenital Diaphragmatic Hernia

See how your Anki deck covers this topic.

Upload your deck for a free audit →